{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:00:59Z","timestamp":1790031659191,"version":"4.0.1"},"reference-count":141,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.drudis.2026.104801","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:10:40Z","timestamp":1789024240000},"page":"104801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Flavones in osteosarcoma: Molecular mechanisms, antitumor activity, and translational challenges"],"prefix":"10.1016","volume":"31","author":[{"given":"Ko-Hsiu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renn-Chia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng\u2010Ying","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-7927","authenticated-orcid":false,"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104801_b0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10555-012-9347-y","article-title":"Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities","volume":"31","author":"Weng","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.drudis.2026.104801_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.109114","article-title":"Phenolic composition, antioxidant potential and health benefits of citrus peel","volume":"132","author":"Singh","year":"2020","journal-title":"Food Res Int"},{"key":"10.1016\/j.drudis.2026.104801_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9966750","article-title":"Flavonols and flavones as potential anti-inflammatory, antioxidant, and antibacterial compounds","volume":"2022","author":"Chagas","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.drudis.2026.104801_b0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pbi.2020.04.004","article-title":"Conservation and diversification of flavonoid metabolism in the plant kingdom","volume":"55","author":"Wen","year":"2020","journal-title":"Curr Opin Plant Biol"},{"key":"10.1016\/j.drudis.2026.104801_b0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cbi.2014.07.006","article-title":"Analysis of the erythroid differentiation effect of flavonoid apigenin on K562 human chronic leukemia cells","volume":"220","author":"Isoda","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.drudis.2026.104801_b0030","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1039\/b802662a","article-title":"Dietary phenolics: chemistry, bioavailability and effects on health","volume":"26","author":"Crozier","year":"2009","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.drudis.2026.104801_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13167-021-00242-5","article-title":"Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles","volume":"12","author":"Liskova","year":"2021","journal-title":"EPMA J"},{"key":"10.1016\/j.drudis.2026.104801_b0040","first-page":"12","article-title":"Bioactive flavonoids in medicinal plants: Structure, activity and biological fate","volume":"13","author":"Wang","year":"2018","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.drudis.2026.104801_b0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104801_b0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrm2455","article-title":"Cancer as an overhealing wound: an old hypothesis revisited","volume":"9","author":"Schafer","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104801_b0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2026.104801_b0060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","article-title":"Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis","volume":"572","author":"Wellenstein","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104801_b0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/antiox8020035","article-title":"Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin","volume":"8","author":"Ginwala","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.drudis.2026.104801_b0075","doi-asserted-by":"crossref","first-page":"688","DOI":"10.6004\/jnccn.2013.0088","article-title":"Bone cancer","volume":"11","author":"Biermann","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.drudis.2026.104801_b0080","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/17453670610013268","article-title":"Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients","volume":"77","author":"Bacci","year":"2006","journal-title":"Acta Orthop"},{"key":"10.1016\/j.drudis.2026.104801_b0085","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.7150\/ijbs.80590","article-title":"Curcumin and its analogs and carriers: potential therapeutic strategies for human osteosarcoma","volume":"19","author":"Lu","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.drudis.2026.104801_b0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.drudis.2026.104801_b0095","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/pbc.21596","article-title":"Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee","volume":"51","author":"Meyer","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.drudis.2026.104801_b0105","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/annonc\/mdn731","article-title":"Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases","volume":"20","author":"Aljubran","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1200\/JCO.2005.04.063","article-title":"Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)","volume":"23","author":"Kempf-Bielack","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107611","article-title":"New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma","author":"Lu","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.drudis.2026.104801_b0125","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.3390\/cancers13133200","article-title":"Poorly differentiated and anaplastic thyroid cancer: insights into genomics, microenvironment and new drugs","volume":"13","author":"Prete","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2026.104801_b0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104801_b0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2026.104801_b0140","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104801_b0145","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.7150\/ijbs.25720","article-title":"Effect of stromal cells in tumor microenvironment on metastasis initiation","volume":"14","author":"Guo","year":"2018","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.drudis.2026.104801_b0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tcb.2018.02.003","article-title":"Apoptotic caspases: multiple or mistaken identities?","volume":"28","author":"McArthur","year":"2018","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.drudis.2026.104801_b0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","article-title":"Understanding apoptosis and apoptotic pathways targeted cancer therapeutics","volume":"9","author":"Jan","year":"2019","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.drudis.2026.104801_b0160","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104801_b0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-020-09845-2","article-title":"New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence","volume":"39","author":"Lu","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.drudis.2026.104801_b0170","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.18632\/oncotarget.7138","article-title":"Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104801_b0175","doi-asserted-by":"crossref","first-page":"35208","DOI":"10.18632\/oncotarget.9106","article-title":"Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104801_b0180","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.3390\/ijms19113568","article-title":"Targeting cancer with phytochemicals via their fine tuning of the cell survival signaling pathways","volume":"19","author":"Chirumbolo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104801_b0185","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cells8121618","article-title":"Molecular and cellular mechanisms of melatonin in osteosarcoma","volume":"8","author":"Lu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104801_b0190","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.phytochem.2005.07.013","article-title":"Flavones and flavone synthases","volume":"66","author":"Martens","year":"2005","journal-title":"Phytochemistry"},{"key":"10.1016\/j.drudis.2026.104801_b0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3945\/an.116.012948","article-title":"Flavones: food sources, bioavailability, metabolism, and bioactivity","volume":"8","author":"Hostetler","year":"2017","journal-title":"Adv Nutr"},{"key":"10.1016\/j.drudis.2026.104801_b0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01185278","article-title":"Determination of flavone C-glycosides in tea","volume":"197","author":"Engelhardt","year":"1993","journal-title":"Z Lebensm Unters Forsch"},{"key":"10.1016\/j.drudis.2026.104801_b0205","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0031-9422(00)00235-1","article-title":"Advances in flavonoid research since 1992","volume":"55","author":"Harborne","year":"2000","journal-title":"Phytochemistry"},{"key":"10.1016\/j.drudis.2026.104801_b0210","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1104\/pp.15.00515","article-title":"The identification of maize and Arabidopsis type I FLAVONE SYNTHASEs links flavones with hormones and biotic interactions","volume":"169","author":"Falcone Ferreyra","year":"2015","journal-title":"Plant Physiol"},{"key":"10.1016\/j.drudis.2026.104801_b0215","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/tox.22380","article-title":"Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways","volume":"32","author":"Chang","year":"2017","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.drudis.2026.104801_b0220","doi-asserted-by":"crossref","first-page":"12444","DOI":"10.1039\/C5NR07887C","article-title":"Therapeutic application of anti-angiogenic nanomaterials in cancers","volume":"8","author":"Mukherjee","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2026.104801_b0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.fct.2016.09.006","article-title":"3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA\/MMP-2 via FAK-Src to MEK\/ERK and RhoA\/MLC2 pathways and reduces 143B tumor growth in vivo","volume":"97","author":"Lu","year":"2016","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.drudis.2026.104801_b0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000090736","article-title":"Bioavailability of apigenin from apiin-rich parsley in humans","volume":"50","author":"Meyer","year":"2006","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.drudis.2026.104801_b0235","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S000711450999170X","article-title":"The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake","volume":"103","author":"Cao","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/j.drudis.2026.104801_b0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.phymed.2003.11.002","article-title":"Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans","volume":"12","author":"Wittemer","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2026.104801_b0245","first-page":"434","article-title":"Evaluation of the effect of luteolin on the hepatic and hematopoietic systems in albino rats","volume":"10","author":"Orji","year":"2020","journal-title":"J Clin Toxicol"},{"key":"10.1016\/j.drudis.2026.104801_b0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S000711459900080X","article-title":"Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects","volume":"81","author":"Nielsen","year":"1999","journal-title":"Br J Nutr"},{"key":"10.1016\/j.drudis.2026.104801_b0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpba.2005.10.019","article-title":"Determination and assay validation of luteolin and apigenin in human urine after oral administration of tablet of Chrysanthemum morifolium extract by HPLC","volume":"41","author":"Li","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.drudis.2026.104801_b0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00394-003-0397-3","article-title":"Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans","volume":"42","author":"Nemeth","year":"2003","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.drudis.2026.104801_b0265","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.103.053496","article-title":"Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model","volume":"307","author":"Hu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.drudis.2026.104801_b0270","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1017\/S0007114507336830","article-title":"Metabolism of flavone C-glucosides and p-coumaric acid from antioxidant of bamboo leaves (AOB) in rats","volume":"97","author":"Zhang","year":"2007","journal-title":"Br J Nutr"},{"key":"10.1016\/j.drudis.2026.104801_b0275","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1021\/np50059a010","article-title":"Metabolism of homoorientin by human intestinal bacteria","volume":"51","author":"Hattori","year":"1988","journal-title":"J Nat Prod"},{"key":"10.1016\/j.drudis.2026.104801_b0280","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.foodchem.2011.03.029","article-title":"Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations","volume":"128","author":"Breiter","year":"2011","journal-title":"Food Chem"},{"key":"10.1016\/j.drudis.2026.104801_b0285","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.phymed.2009.12.010","article-title":"The pharmacokinetics of C-glycosyl flavones of Hawthorn leaf flavonoids in rat after single dose oral administration","volume":"17","author":"Ma","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2026.104801_b0290","first-page":"1521","article-title":"Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation","volume":"29","author":"Shimoi","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.drudis.2026.104801_b0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/03602532.2014.1003649","article-title":"Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure-activity\/property relationship-based approach in the study of bioavailability and bioactivity","volume":"47","author":"Gonzales","year":"2015","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.drudis.2026.104801_b0300","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.foodchem.2013.03.048","article-title":"The influence of protein-flavonoid interactions on protein digestibility in vitro and the antioxidant quality of breads enriched with onion skin","volume":"141","author":"Swieca","year":"2013","journal-title":"Food Chem"},{"key":"10.1016\/j.drudis.2026.104801_b0305","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0753-3322(97)88045-6","article-title":"Absorption, metabolism and health effects of dietary flavonoids in man","volume":"51","author":"Hollman","year":"1997","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104801_b0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3945\/ajcn.116.136051","article-title":"The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids","volume":"105","author":"Cassidy","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.drudis.2026.104801_b0315","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.freeradbiomed.2006.04.033","article-title":"Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?","volume":"41","author":"Lotito","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2026.104801_b0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.foodchem.2018.04.039","article-title":"Phenolic compounds as beneficial phytochemicals in pomegranate (Punica granatum L.) peel: a review","volume":"261","author":"Singh","year":"2018","journal-title":"Food Chem"},{"key":"10.1016\/j.drudis.2026.104801_b0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.foodchem.2014.07.062","article-title":"Flavonoids and phenolic acids from cranberry juice are bioavailable and bioactive in healthy older adults","volume":"168","author":"McKay","year":"2015","journal-title":"Food Chem"},{"key":"10.1016\/j.drudis.2026.104801_b0330","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1021\/jf303446x","article-title":"Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo","volume":"60","author":"Lin","year":"2012","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.drudis.2026.104801_b0335","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/or.2015.4022","article-title":"Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt\/beta-catenin signaling pathway","volume":"34","author":"Liu","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.drudis.2026.104801_b0340","doi-asserted-by":"crossref","first-page":"13179","DOI":"10.3390\/ijms232113179","article-title":"Apigenin modulates AnxA6- and TNAP-mediated osteoblast mineralization","volume":"23","author":"Mroczek","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104801_b0345","article-title":"Apigenin suppresses the Warburg effect and stem-like properties in SOSP-9607 cells by inactivating the PI3K\/Akt\/mTOR signaling pathway","volume":"2022","author":"Shi","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.drudis.2026.104801_b0350","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ptr.6869","article-title":"Plant flavone Chrysin as an emerging histone deacetylase inhibitor for prosperous epigenetic-based anticancer therapy","volume":"35","author":"Ganai","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.drudis.2026.104801_b0355","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/cbin.11879","article-title":"Chrysin sensitizes osteosarcoma cells against TRAIL-induced apoptosis","volume":"46","author":"Xie","year":"2022","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.drudis.2026.104801_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100429","article-title":"Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN\/beta-catenin\/MDR1 signaling axis by upregulating miR-384","volume":"34","author":"Qin","year":"2022","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0365","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0973-1296.204566","article-title":"Flavonoids isolated from the flowers of Limonium bicolor and their in vitro antitumor evaluation","volume":"13","author":"Chen","year":"2017","journal-title":"Pharmacogn Mag"},{"key":"10.1016\/j.drudis.2026.104801_b0370","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12935-023-03046-x","article-title":"Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma","volume":"23","author":"Huang","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.drudis.2026.104801_b0375","first-page":"531","article-title":"Molecular mechanisms of luteolin induced growth inhibition and apoptosis of human osteosarcoma cells","volume":"14","author":"Wang","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.drudis.2026.104801_b0380","first-page":"15190","article-title":"The flavonoid luteolin enhances doxorubicin-induced autophagy in human osteosarcoma U2OS cells","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.drudis.2026.104801_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100124","article-title":"Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630","volume":"9","author":"Sakurai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104801_b0390","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/antiox12091744","article-title":"Gossypetin is a novel modulator of inflammatory cytokine production and a suppressor of osteosarcoma cell growth","volume":"12","author":"Proenca","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.drudis.2026.104801_b0395","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.fct.2012.12.019","article-title":"Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells","volume":"53","author":"Zhang","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.drudis.2026.104801_b0400","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10495-014-0995-y","article-title":"HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis","volume":"19","author":"Ding","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.drudis.2026.104801_b0405","first-page":"1104","article-title":"Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR\u2011183\/Ezrin pathway","volume":"18","author":"Zhang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.drudis.2026.104801_b0410","first-page":"342","article-title":"Inhibitory effect of baicalein on the proliferation and invasion of osteosarcoma cells and mechanism","volume":"31","author":"Tang","year":"2015","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.drudis.2026.104801_b0415","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10799893.2020.1713807","article-title":"Baicalein inhibits cell development, metastasis and EMT and induces apoptosis by regulating ERK signaling pathway in osteosarcoma","volume":"40","author":"Lin","year":"2020","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.drudis.2026.104801_b0420","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1007\/s13277-015-3122-y","article-title":"Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression","volume":"36","author":"Ye","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.drudis.2026.104801_b0425","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11010-015-2410-6","article-title":"Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway","volume":"405","author":"He","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.drudis.2026.104801_b0430","doi-asserted-by":"crossref","first-page":"86098","DOI":"10.18632\/oncotarget.20987","article-title":"Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt\/beta-catenin signaling pathway","volume":"8","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104801_b0435","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jot.2021.12.001","article-title":"Baicalein mediates the anti-tumor activity in osteosarcoma through lncRNA-NEF driven Wnt\/beta-catenin signaling regulatory axis","volume":"33","author":"Zhang","year":"2022","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.drudis.2026.104801_b0440","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3906\/sag-2001-161","article-title":"The effect of baicalein on Wnt\/beta-catenin pathway and miR-25 expression in Saos-2 osteosarcoma cell line","volume":"50","author":"Orenlili Yaylagul","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.drudis.2026.104801_b0445","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.drudis.2026.104801_b0450","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9984112","article-title":"Analysis and construction of a competitive endogenous RNA regulatory network of baicalin-induced apoptosis in human osteosarcoma cells","volume":"2021","author":"Lan","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2026.104801_b0455","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/CAD.0000000000000495","article-title":"Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-beta1-induced epithelial-to-mesenchymal transition","volume":"28","author":"Wang","year":"2017","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.drudis.2026.104801_b0460","first-page":"3188","article-title":"Baicalin inhibits growth and induces apoptosis of human osteosarcoma cells by suppressing the AKT pathway","volume":"18","author":"Liu","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.drudis.2026.104801_b0465","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.24976\/Discov.Med.202436187.151","article-title":"Baicalin plays an anti-osteosarcoma role in vitro and promotes osteogenic differentiation by inhibiting NF-\u03baB signaling","volume":"36","author":"Zhao","year":"2024","journal-title":"Discov Med"},{"key":"10.1016\/j.drudis.2026.104801_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100415","article-title":"Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K\/Akt\/mTOR, ERK1\/2 and beta-catenin signaling pathways","volume":"33","author":"Pang","year":"2022","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0475","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1080\/14786419.2017.1359173","article-title":"Baicalin induces apoptosis in human osteosarcoma cell through ROS-mediated mitochondrial pathway","volume":"32","author":"Wan","year":"2018","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.drudis.2026.104801_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154881","article-title":"Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2\/xCT\/GPX4 regulatory axis","volume":"116","author":"Wen","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2026.104801_b0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/DDDT.S489092","article-title":"Scutellarein inhibits osteosarcoma growth by targeting the TLR4\/TRAF6\/NF-\u03baB pathway","volume":"19","author":"Shi","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.drudis.2026.104801_b0490","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1111\/jcmm.16809","article-title":"EGR1 promoted anticancer effects of Scutellarin via regulating LINC00857\/miR-150-5p\/c-Myc in osteosarcoma","volume":"25","author":"Han","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.drudis.2026.104801_b0495","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40659-021-00363-1","article-title":"Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3\/c-Myc signaling pathway in human osteosarcoma cells","volume":"54","author":"Ning","year":"2021","journal-title":"Biol Res"},{"key":"10.1016\/j.drudis.2026.104801_b0500","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.2147\/DDDT.S275148","article-title":"Acacetin induces apoptosis in human osteosarcoma cells by modulation of ROS\/JNK activation","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.drudis.2026.104801_b0505","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/abbs\/gmab060","article-title":"7,8-Dihydroxyflavone suppresses proliferation and induces apoptosis of human osteosarcoma cells","volume":"53","author":"Zhao","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.drudis.2026.104801_b0510","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1186\/s12967-025-07128-4","article-title":"Hispidulin suppresses osteosarcoma by directly targeting FABP4 to disrupt lipid metabolism and inhibit the PI3K\/AKT pathway","volume":"23","author":"Yuan","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2026.104801_b0515","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13046-021-01903-z","article-title":"Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo","volume":"40","author":"Jia","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104801_b0520","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1186\/s12967-023-04682-7","article-title":"Cirsiliol induces autophagy and mitochondrial apoptosis through the AKT\/FOXO1 axis and influences methotrexate resistance in osteosarcoma","volume":"21","author":"Luo","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2026.104801_b0525","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/bph.15435","article-title":"The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer","volume":"178","author":"He","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2026.104801_b0530","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1248\/bpb.31.2063","article-title":"Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from Cirsium chanroenicum","volume":"31","author":"Lim","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.drudis.2026.104801_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113323","article-title":"Pectolinarigenin acts as a potential anti-osteosarcoma agent via mediating SHP-1\/JAK2\/STAT3 signaling","volume":"153","author":"Zhang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104801_b0540","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/nano9081089","article-title":"Tangeretin-assisted platinum nanoparticles enhance the apoptotic properties of doxorubicin: combination therapy for osteosarcoma treatment","volume":"9","author":"Gurunathan","year":"2019","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.drudis.2026.104801_b0545","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s12672-025-03221-8","article-title":"Identification of key targets and exploration of therapeutic molecular mechanisms of natural compound tangeretin in osteosarcoma","volume":"16","author":"Yanzhang","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0550","first-page":"217","article-title":"Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways","volume":"39","author":"Lin","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0555","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12906-017-1788-y","article-title":"Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression","volume":"17","author":"Huynh","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.drudis.2026.104801_b0560","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.21873\/invivo.11878","article-title":"Wogonin influences osteosarcoma stem cell stemness through ROS-dependent signaling","volume":"34","author":"Koh","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.drudis.2026.104801_b0565","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70054","article-title":"The molecular mechanisms underlying the antineoplastic profile of vitexin 2''-O-\u03b1-L-rhamnopyranoside from Cordyline australis (G. Frost.): Isolation and constituent profiling","volume":"358","author":"Raslan","year":"2025","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.drudis.2026.104801_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116039","article-title":"Natural products in traditional Chinese medicine: Molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems","volume":"170","author":"Song","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104801_b0575","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/1541-4337.12725","article-title":"Advancements in liposome technology: Preparation techniques and applications in food, functional foods, and bioactive delivery: a review","volume":"20","author":"Ajeeshkumar","year":"2021","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"10.1016\/j.drudis.2026.104801_b0580","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2016.09.017","article-title":"Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives","volume":"241","author":"Alexander","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104801_b0585","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2013.06.030","article-title":"Recent expansions in an emergent novel drug delivery technology: Emulgel","volume":"171","author":"Ajazuddin","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104801_b0590","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2147\/IJN.S51578","article-title":"Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation","volume":"8","author":"Zhao","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2026.104801_b0595","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1568026623666221128144258","article-title":"The flavonoid components of Scutellaria baicalensis: Biopharmaceutical properties and their improvement using nanoformulation techniques","volume":"23","author":"Wang","year":"2023","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.drudis.2026.104801_b0600","first-page":"1","article-title":"Nanotechnology-based drug delivery systems and herbal medicines: a review","volume":"9","author":"Bonifacio","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2026.104801_b0605","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2147\/IJN.S37984","article-title":"Development of a novel niosomal system for oral delivery of Ginkgo biloba extract","volume":"8","author":"Jin","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2026.104801_b0610","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","article-title":"Cyclodextrins: structure, physicochemical properties and pharmaceutical applications","volume":"535","author":"Jansook","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2026.104801_b0615","article-title":"Curcumin in human osteosarcoma: from analogs to carriers","volume":"28","author":"Lu","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104801_b0620","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104801_b0625","first-page":"742","article-title":"Progress in nanomedicine: approved and investigational nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"P T"},{"key":"10.1016\/j.drudis.2026.104801_b0630","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.drudis.2026.104801_b0635","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104801_b0640","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2026.104801_b0645","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2026.104801_b0650","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jsps.2015.03.022","article-title":"Methods of synthesis of hydrogels ... a review","volume":"24","author":"Akhtar","year":"2016","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.drudis.2026.104801_b0655","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1440-1681.12581","article-title":"Molecular mechanisms for tumour resistance to chemotherapy","volume":"43","author":"Pan","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.drudis.2026.104801_b0660","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fonc.2020.00005","article-title":"Metabolic symbiosis in chemoresistance: refocusing the role of aerobic glycolysis","volume":"10","author":"Ma","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104801_b0665","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: Focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.drudis.2026.104801_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101034","article-title":"Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury","volume":"14","author":"Yang","year":"2024","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.drudis.2026.104801_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156982","article-title":"Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury","volume":"145","author":"Pu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2026.104801_b0680","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.drudis.2026.104801_b0685","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"DNA-PKcs-driven YAP1 phosphorylation and nuclear translocation: a key regulator of ferroptosis in hyperglycemia-induced cardiac dysfunction in type 1 diabetes","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2026.104801_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157288","article-title":"Astragaloside VI attenuates mechanical stress-induced cardiac remodeling through piezo1-VDAC1 dependent endoplasmic reticulum unfolded protein response","volume":"148","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2026.104801_b0695","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12951-025-03667-6","article-title":"A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair","volume":"23","author":"Shi","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.drudis.2026.104801_b0700","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.7150\/ijbs.102424","article-title":"Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression","volume":"20","author":"Chang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.drudis.2026.104801_b0705","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.7150\/ijbs.95853","article-title":"Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia\/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy","volume":"20","author":"Wang","year":"2024","journal-title":"Int J Biol Sci"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:04:09Z","timestamp":1790028249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626002060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1359644626002060"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104801","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flavones in osteosarcoma: Molecular mechanisms, antitumor activity, and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104801"}}